Clinical Pipeline

Galapagos is progressing one of the largest pipelines in biotech, with a broad range of disease areas being explored in Phase 2 and Phase 3 with filgotinib, multiple Phase 1 and Phase 2 studies with other clinical programs, and approximately 20 discovery programs. 

Our programs with filgotinib

Pipeline April 2017 (1)

Our programs in CF, IPF, osteoarthritis, atopic dermatitis and psoriasis

Pipeline April 2017 (2)